Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | GFER | P55789 | 1/20 | 0.50 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.50 |
| ▸ | CES2 | O00748 | 2/20 | 0.45 |
| ▸ | CES1 | P23141 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | DAO | P14920 | 1/20 | 0.45 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | MAOA | P21397 | 2/20 | 0.42 |
| ▸ | MAOB | P27338 | 2/20 | 0.42 |
| ▸ | AKT1 | P31749 | 1/20 | 0.42 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | F10 | P00742 | 1/20 | 0.41 |
| ▸ | F12 | P00748 | 1/20 | 0.41 |
| ▸ | F7 | P08709 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL28340939 | 0.97 | MEN1 (0.61) | MEN1KMT2AMAPTHSD17B10HTT | |
| SCHEMBL7930063 | 0.97 | MEN1 (0.61) | MEN1KMT2AMAPTHSD17B10HTT | |
| SCHEMBL3844822 | 0.97 | MEN1 (0.61) | MEN1KMT2AMAPTHSD17B10HTT | |
| SCHEMBL26736 | 0.97 | MEN1 (0.61) | MEN1KMT2AMAPTHSD17B10HTT | |
| Benzene SCHEMBL9731493 | 0.97 | MEN1 (0.61) | MEN1KMT2AMAPTHSD17B10HTT | |
| SCHEMBL894135 | 0.93 | MEN1 (0.65) | MEN1KMT2AMAPTHSD17B10HTT | |
| Hydrochloric Acid SCHEMBL10598447 | 0.93 | KMT2A (0.58) | MEN1KMT2AMAPTHSD17B10HTT | |
| SCHEMBL8210944 | 0.93 | MEN1 (0.58) | MEN1KMT2AMAPTHSD17B10HTT | |
| Ethylene SCHEMBL6524259 | 0.93 | MEN1 (0.58) | MEN1KMT2AMAPTHSD17B10HTT | |
| SCHEMBL11434494 | 0.93 | MEN1 (0.58) | MEN1KMT2AMAPTHSD17B10HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119977978-A | Catalytic synthesis method of chiral pyrazolo hydro-pyran compound | 中国海洋大学 | 2025-05-13 | — | — | CN | claimed |
| CN-117926354-A | Pulse cyanide-free gold electroplating liquid and electroplating method thereof | 深圳市联合蓝海应用材料科技股份有限公司 | 2024-04-26 | — | — | CN | claimed |
| EP-3074116-A1 | FABRICATION AND MODIFICATION OF POLYMER MEMBRANES USING INK-JET PRINTING | B.G. Negev Technologies and Applications Ltd. (IL) | 2016-10-05 | — | — | EP | claimed |
| US-9446393-B2 | Transition metal complexes for enantioselective catalysis of carbon-carbon, carbon-heteroatom, and carbon-hydrogen bond forming reactions | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2016-09-20 | — | — | US | claimed |
| US-20150165429-A1 | TRANSITION METAL COMPLEXES FOR ENANTIOSELECTIVE CATALYSIS OF CARBON-CARBON, CARBON-HETEROATOM, AND CARBON-HYDROGEN BOND FORMING REACTIONS | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2015-06-18 | — | — | US | claimed |
| WO-2015079442-A1 | FABRICATION AND MODIFICATION OF POLYMER MEMBRANES USING INK-JET PRINTING | B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD (IL) | 2015-06-04 | — | — | WO | claimed |
| WO-2014018978-A2 | TRANSITION METAL COMPLEXES FOR ENANTIOSELECTIVE CATALYSIS OF CARBON-CARBON, CARBON-HETEROATOM, AND CARBON-HYDROGEN BOND FORMING REACTIONS | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2014-01-30 | — | — | WO | claimed |
| JP-10068722-A | — | — | None | — | — | JP | disclosed |
| US-20250382392-A1 | AMIDE LINKAGES OF SUGAR MOIETIES TO AMINE TERMINATED LEASHES ATTACHED TO CARBOHYDRATE POLYMERS | NAVIDEA BIOPHARMACEUTICALS INC (US) | 2025-12-18 | — | — | US | disclosed |
| US-12404349-B2 | Amide linkages of sugar moieties to amine terminated leashes attached to carbohydrate polymers | NAVIDEA BIOPHARMACEUTICALS, INC. (US) | 2025-09-02 | — | — | US | disclosed |
| EP-4598583-A2 | AMIDE LINKAGES OF SUGAR MOIETIES TO AMINE TERMINATED LEASHES ATTACHED TO CARBOHYDRATE POLYMERS | Navidea Biopharmaceuticals, Inc. (US) | 2025-08-13 | — | — | EP | disclosed |
| US-20250009892-A1 | DELIVERY SYSTEMS AND METHODS FOR REACTIVE HYDROXYL-CONTAINING COMPOUNDS | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2025-01-09 | — | — | US | disclosed |
| US-12178829-B2 | Altering net charge on mannosylated dextrans to maximize target tissue uptake and off target competitive blocking | NAVIDEA BIOPHARMACEUTICALS, INC. (US) | 2024-12-31 | — | — | US | disclosed |
| EP-0586520-A1 | BACKBONE MODIFIED OLIGONUCLEOTIDE ANALOGS | ISIS PHARMACEUTICALS, INC. (US) | 1994-03-16 | — | — | EP | disclosed |
| EP-0586570-A1 | BACKBONE MODIFIED OLIGONUCLEOTIDE ANALOGUES | ISIS PHARMACEUTICALS, INC. (US) | 1994-03-16 | — | — | EP | disclosed |
| WO-1992020822-A1 | BACKBONE MODIFIED OLIGONUCLEOTIDE ANALOGUES | ISIS PHARMACEUTICALS, INC. (US) | 1992-11-26 | — | — | WO | disclosed |
| WO-1992020823-A1 | BACKBONE MODIFIED OLIGONUCLEOTIDE ANALOGS | ISIS PHARMACEUTICALS, INC. (US) | 1992-11-26 | — | — | WO | disclosed |
| EP-0129527-B1 | VULCANISABLE RUBBER COMPOSITION AND COMPOUNDS USEFUL AS STABILISING AGENTS FOR RUBBER VULCANISATES | MONSANTO EUROPE S.A./N.V. (BE) | 1989-07-12 | — | — | EP | disclosed |
| EP-0109955-B1 | RUBBER/METAL COMPOSITES | MONSANTO EUROPE S.A./N.V. (BE) | 1988-01-20 | — | — | EP | disclosed |
| EP-0070143-B1 | ORGANIC THIOSULPHATES AND THIOSULPHONATES USEFUL AS STABILISING AGENTS FOR RUBBER VULCANISATES | MONSANTO EUROPE S.A./N.V. (BE) | 1985-02-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12178829-B2 | Altering net charge on mannosylated dextrans to maximize target tissue uptake and off target competitive blocking | CD209, FUT6, SIGLEC7 | MEN1 284/4885KMT2A 3751/4885MAPT 2668/4885 |
| US-12404349-B2 | Amide linkages of sugar moieties to amine terminated leashes attached to carbohydrate polymers | MASP2, CLEC4M, GALR3 | MEN1 2055/4885KMT2A 2195/4885MAPT 2751/4885 |
| US-20250382392-A1 | AMIDE LINKAGES OF SUGAR MOIETIES TO AMINE TERMINATED LEASHES ATTACHED TO CARBOHYDRATE POLYMERS | MASP2, CLEC4M, GALR3 | MEN1 2055/4885KMT2A 2195/4885MAPT 2751/4885 |
| US-20150165429-A1 | TRANSITION METAL COMPLEXES FOR ENANTIOSELECTIVE CATALYSIS OF CARBON-CARBON, CARBON-HETEROATOM, AND CARBON-HYDROGEN BOND FORMING REACTIONS | SOD1, YWHAZ, L1CAM | MEN1 3811/4885KMT2A 840/4885MAPT 4214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.